Financials
- Market Capitalization 40.67 B
- Employee 883
- Founded 2014
- CEO N/A
- Website www.revmed.com
- Headquarter Delaware, United States
- FIGI BBG00829F4P8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-13.39
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 218 | REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 746.54 USD | +0.94% | +1.66% | -5.38% | +35.24% | 76.86 B USD | ||
| 309 | ARGX argenx SE - American Depositary Shares | 825.03 USD | +0.78% | -10.34% | -17.87% | +3.55% | 51.06 B USD | ||
| 434 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 232.68 USD | +3.63% | +6.56% | -6.99% | -48.99% | 31.13 B USD | ||
| 496 | ROIV Roivant Sciences Ltd. - Common Shares | 35.44 USD | +3.60% | -1.50% | -12.80% | +93.56% | 25.60 B USD |